Cronos Group Inc. to Speak at 38th Annual ROTH Conference
Digest more
Net revenue of $44.5 million in Q4 2025 increased by $14.2 million from Q4 2024. The increase was primarily due to higher cannabis flower sales in Israel and other countries, which carry no excise ...
Shares of Cronos Group (NASDAQ: CRON) were sinking 4.1% lower as of 10:57 a.m. ET on Tuesday and fell as much as 5.7% earlier in the day. The decline came after the U.S. Drug Enforcement ...
Hosted on MSN
Cronos just bought Europe’s top cannabis producer — is this the catalyst investors have waited 5 years for?
For years, North American cannabis investors have endured a brutal hangover. Cronos Group (NASDAQ:CRON), once a darling of the 2018-2019 marijuana mania, watched its share price collapse more than ...
Cronos Group (NASDAQ:CRON) reported what executives described as a record year in 2025, with organic net revenue growth of 25 ...
Cronos Group (NASDAQ: CRON) stock jumped 9.4% through 11:30 a.m. ET Tuesday after beating Wall Street forecasts for Q3 earnings this morning. Heading into the report, analysts expected Cronos to ...
For its second quarter, Cronos -- which reports in U.S. dollars -- took in nearly $27.8 million in revenue, a figure almost 50% higher than the $19 million it earned in the same period of 2023. On a ...
TORONTO, June 20, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, announced an expansion of Cronos Growing Company ...
Cronos Group’s smaller size and production capacity would be less of an issue if its market cap were not the third largest of firms listed in Figure 5. This lofty valuation makes it even harder for ...
Cronos Group Inc. (NASDAQ:CRON) is one of the High Growth Penny Stocks That Are Profitable in 2025. On July 2, Cronos Group Inc. (NASDAQ:CRON) announced expanding its reach in Europe by forging a ...
Shares of Cronos Group Inc. CRON slipped 1.14% to $2.60 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 1.02% to ...
Analysts covering Cronos Group are centering their views around a CA$4.50 price target and a CA$4.235 fair value estimate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results